StanislawRBurzynskiMD

Clinical Trials

• Antineoplastons A10 and AS2-1 In Patients With Carcinoma of the Bladder Start of enrollment: 1996 May 06

  Terminated

  Phase 2

• Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer Start of enrollment: 1996 Aug 21

  Terminated

  Phase 2

• Antineoplaston Therapy in Treating Women With Stage IV Breast Cancer Start of enrollment: 1996 Mar 18

  Terminated

  Phase 2

• Antineoplaston Therapy in Treating Patients With Newly-diagnosed Glioblastoma Multiforme Start of enrollment: 1995 Mar 14

  Completed

  Phase 2

• Antineoplaston Therapy in Treating Patients With Brain Tumors Start of enrollment: 1996 Jul 01

  Completed

  Phase 2

• Antineoplaston Therapy in Treating Children With Brain Tumors Start of enrollment: 1996 Sep 01

  Completed

  Phase 2

• Antineoplaston Therapy in Treating Patients With Brain Stem Glioma Start of enrollment: 1996 Mar 01

  Completed

  Phase 2

• Antineoplaston Therapy in Treating Children With Primitive Neuroectodermal Tumors Start of enrollment: 1996 Apr 01

  Completed

  Phase 2

• Antineoplaston Therapy in Treating Children With Low-Grade Astrocytoma Start of enrollment: 1996 Jul 01

  Completed

  Phase 2

• Antineoplaston Therapy in Treating Children With Rhabdoid Tumor of the Central Nervous System Start of enrollment: 1996 Feb 01

  Terminated

  Phase 2

• Antineoplaston Therapy in Treating Patients With Anaplastic Astrocytoma Start of enrollment: 1996 Mar 01

  Completed

  Phase 2

• Antineoplaston Therapy in Treating Patients With Low-Grade Astrocytoma Start of enrollment: 1996 Mar 01

  Terminated

  Phase 2

• Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Oligodendroglioma Start of enrollment: 1996 May 01

  Terminated

  Phase 2

• Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Mixed Gliomas Start of enrollment: 1996 Mar 01

  Completed

  Phase 2

• Antineoplaston Therapy in Treating Adults With Residual/Recurrent/Progressive Glioblastoma Multiforme Start of enrollment: 1996 Mar 14

  Completed

  Phase 2

• Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors Start of enrollment: 1996 Feb 01

  Completed

  Phase 2

• Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors Start of enrollment: 1996 Mar 01

  Terminated

  Phase 2

• Antineoplaston Therapy in Treating Children With Visual Pathway Glioma Start of enrollment: 1996 Jun 01

  Completed

  Phase 2

• Antineoplaston Therapy in Treating Patients With Ependymoma Start of enrollment: 1966 Jul 01

  Terminated

  Phase 2

• Antineoplaston Therapy in Treating Patients With Meningioma Start of enrollment: 1998 Jun 01

  Terminated

  Phase 2

• Antineoplaston Therapy in Treating Patients With Metastatic or Unresectable Colon Cancer Start of enrollment: 1996 Apr 10

  Terminated

  Phase 2

• Antineoplaston Therapy in Treating Patients With Cancer of the Esophagus Start of enrollment: 1996 May 30

  Terminated

  Phase 2

• Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer Start of enrollment: 1996 May 06

  Terminated

  Phase 2

• Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer Start of enrollment: 1996 Mar 20

  Terminated

  Phase 2

• Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer Start of enrollment: 1996 Apr 10

  Terminated

  Phase 2

• Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer Start of enrollment: 1996 Mar 26

  Terminated

  Phase 2

• Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer Start of enrollment: 1996 Mar 27

  Terminated

  Phase 2

• Antineoplaston Therapy in Treating Patients With Recurrent or Extensive-Stage Small Cell Lung Cancer Start of enrollment: 1996 Mar 07

  Terminated

  Phase 2

• Antineoplaston Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer Start of enrollment: 1996 Aug 21

  Terminated

  Phase 2

• Antineoplaston Therapy in Treating Patients With Non-Hodgkin's Lymphoma Start of enrollment: 1997 Oct 13

  Terminated

  Phase 2

• Antineoplaston Therapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma Start of enrollment: 1996 Mar 06

  Completed

  Phase 2

• Antineoplaston Therapy in Treating Patients With Intermediate-Grade Stage II - IV Non-Hodgkin's Lymphoma Start of enrollment: 1996 Mar 11

  Terminated

  Phase 2

• Antineoplaston Therapy in Treating Patients With High-Grade Stage II - Stage IV Non-Hodgkin's Lymphoma Start of enrollment: 1996 Apr 10

  Terminated

  Phase 2

• Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma Start of enrollment: 1996 Mar 08

  Terminated

  Phase 2

• Antineoplaston Therapy in Treating Patients With Stage IV Melanoma Start of enrollment: 1996 Mar 27

  Terminated

  Phase 2

• Antineoplaston Therapy in Treating Patients With Multiple Myeloma Start of enrollment: 1996 Apr 04

  Terminated

  Phase 2

• Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Waldenstrom's Macroglobulinemia Start of enrollment: 1999 Feb 18

  Withdrawn

  Phase 2

• Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Neuroblastoma Start of enrollment: 1996 Dec 16

  Terminated

  Phase 2

• Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Primitive Neuroectodermal Tumors Start of enrollment: 1996 Dec 12

  Terminated

  Phase 2

• Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer Start of enrollment: 1996 Mar 27

  Terminated

  Phase 2

• Antineoplaston Therapy in Treating Patients With Stage IV Kidney Cancer Start of enrollment: 1996 Mar 27

  Terminated

  Phase 2

• Antineoplaston Therapy in Treating Patients With Soft Tissue Sarcoma Start of enrollment: 1996 Jun 14

  Terminated

  Phase 2

• Antineoplaston Therapy in Treating Patients With Cancer of the Small Intestine Start of enrollment: 1997 Aug 13

  Terminated

  Phase 2

• Antineoplaston Therapy in Treating Patients With Stomach Cancer Start of enrollment: 1996 Oct 04

  Terminated

  Phase 2

• Antineoplaston Therapy in Treating Patients With Stage IV Cancer of the Cervix and/or Vulva Start of enrollment: 1996 Jun 03

  Terminated

  Phase 2

• Antineoplaston Therapy in Treating Patients With Cancer of Unknown Primary Origin Start of enrollment: 1996 Mar 18

  Terminated

  Phase 2

• Antineoplaston Therapy in Treating Patients With Primary Liver Cancer Start of enrollment: 1977 Mar 21

  Terminated

  Phase 2

• Antineoplaston Therapy in Treating Patients With Stage IV Pancreatic Cancer Start of enrollment: 1996 Apr 10

  Terminated

  Phase 2

• Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer Start of enrollment: 1996 Mar 05

  Terminated

  Phase 2

• Antineoplaston Therapy in Treating Patients With Metastatic Prostate Cancer Start of enrollment: 1996 Feb 27

  Terminated

  Phase 2

• Antineoplaston Therapy in Treating Patients With Refractory Stage IV Prostate Cancer Start of enrollment: 1996 Oct 11

  Withdrawn

  Phase 2

• Antineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade Glioma Start of enrollment: 1994 Apr 01

  Terminated

  Phase 2

• Antineoplaston Therapy in Treating Adult Patients With Anaplastic Astrocytoma Start of enrollment: 1995 Apr 01

  Completed

  Phase 2

• Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma Start of enrollment: 2011 Dec 01

  Withdrawn

  Phase 3

• A Study of Atengenal and Astugenal in Diffuse, Intrinsic Pontine Glioma (DIPG) Start of enrollment: 2016 Apr 13

  Suspended

  Phase 2

• Effect of Antineoplaston Therapy on the QT/QTc Interval In Subjects With Diffuse, Intrinsic, Brainstem Glioma Start of enrollment: 2024 Jun 01

  Not yet recruiting

  Phase 3

• Antineoplaston Therapy in Treating Patients With Neurofibroma and Schwannoma Start of enrollment: 1999 Mar 01

  Terminated

  Phase 2

• Study of Antineoplaston Therapy + Radiation vs. Radiation Only in Diffuse, Intrinsic, Brainstem Glioma Start of enrollment: 2024 Jun 01

  Not yet recruiting

  Phase 3

  Roles: Study Chair, Contact

• Join now to see all